<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Everest Medicines Announces Positive Results of Complete Chinese Subpopulation Data from the NEFECON® Global Phase 3 NefIgArd Clinical Trial Published in &#8220;Kidney 360&#8221; Magazine	</title>
	<atom:link href="https://9krapalm.com/everest-medicines-announces-positive-results-of-complete-chinese-subpopulation-data-from-the-nefecon-global-phase-3-nefigard-clinical-trial-published-in-kidney-360-magazine/feed/" rel="self" type="application/rss+xml" />
	<link>https://9krapalm.com/everest-medicines-announces-positive-results-of-complete-chinese-subpopulation-data-from-the-nefecon-global-phase-3-nefigard-clinical-trial-published-in-kidney-360-magazine/</link>
	<description>เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm</description>
	<lastBuildDate>Tue, 22 Oct 2024 00:49:34 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>
</channel>
</rss>
